Showing results (191-200 of 218) with videos related to
Sort By:
Pageof 22
Anticancer Research|December 4, 2018
Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5' and 3' ExonsKyung Jin Eoh, Hyung Seok Park, Ji Soo Park, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 18, 2011
Single port transumbilical laparoscopic surgery for adnexal lesions: a single center experience in KoreaYong Wook Jung, Young Mi Choi, Chan Kyung Chung, et al.International Journal of Radiation Oncology, Biology, Physics|May 27, 2009
Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervixYong Bae Kim, Ik Jae Lee, Song Yih Kim, et al.Cancer Research and Treatment|November 16, 2018
Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian CancerLan Ying Li, Hee Jung Kim, Sun Ae Park, et al.Yonsei Medical Journal|December 4, 2015
Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell LinesYeon Soo Jung, Hee Jung Kim, Seok Kyo Seo, et al.Obstetrics & Gynecology Science|December 12, 2013
The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative surgical site pain compared to intravenous patient-controlled analgesiaDawn Chung, Yoo Jin Lee, Mi Hyun Jo, et al.Cancers|May 14, 2022
Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian CancerYong Jae Lee, Ha Young Woo, Yoo-Na Kim, et al.Cancers|January 25, 2025
SORL1-Mediated EGFR and FGFR4 Regulation Enhances Chemoresistance in Ovarian CancerZiyan Jiang, Fangfang Bi, Zhiping Ge, et al.Journal of Cancer Research and Clinical Oncology|January 23, 2008
Clinical significance of osteopontin expression in cervical cancerHanByoul Cho, Soon Won Hong, Youn Jin Oh, et al.Nature Communications|September 6, 2023
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4Yoo-Na Kim, Boram Park, Jae Weon Kim, et al.Pageof 22